Senate could take on medical device tax in January; NIH backs robotics projects;

@FierceMedDev: ICYMI yesterday: Edwards gains option to acquire startup CardioKinetix in $50M financing. Article | Follow @FierceMedDev

@EmilyWFierce: Stryker's OtisMed to pay more than $80M to settle DOJ case over knee replacement surgical devices. Story | Follow @EmilyWFierce

> Incoming Senate majority leader Mitch McConnell (R-KY) plans to address repealing the Affordable Care Act and medical device tax as soon as January. Story

> The NIH continues to participate in the Interagency National Robotics Initiative to back projects that could help with stroke rehabilitation, guide wheelchairs and assist children with autism spectrum disorder. News

> Cyberonics' clinical trial of its AspireSR generator found decreased seizure duration in epileptic patients. Release

> Aesthetic device company Syneron Medical signed a multiyear agreement with American Medical Systems, a pelvic health medtech company, to supply holmium lasers for the treatment of kidney stones. Release

Biotech News

@FierceBiotech: Bluebird posts more promising results with its rare disease therapy. Story | Follow @FierceBiotech

@DamianFierce: So the billionaire Russian oligarch who bought Watson's Nobel medal for $4.1 million is giving it back because hey. More | Follow @DamianFierce

> Pfizer strikes another immunotherapy deal to widen its oncology pipeline. News

> Lilly and Incyte's oral arthritis drug aces its first Phase III test. Story

> Circassia looks to higher doses to salvage ragweed drug after PhIIb miss. Article

Pharma News

@FiercePharma: Did Merck pay $3B too much for Cubist? Analysts weigh impact of Cubicin patent loss. Story | Follow @FiercePharma

@CarlyHFierce: AbbVie's Humira competition begins with Cadila's biosimilar launch in India. More | Follow @CarlyHFierce

> Long-term painkiller use on the rise, with more patients taking dangerous combos. Story

> J&J discount offer wins NICE over to new use for Stelara. Article

> Valeant temporarily swears off dealmaking to cut debt--and prove it's not desperate. News

Biotech Research News

> Epizyme showcases a successful preclinical lymphoma program for third target. More

> MicroRNA holds clues to predicting progression-free myeloma survival. Report

> New malaria drug unleashes an immune system assault on infected cells. Story

> Could alpha secretase offer a better approach to fighting Alzheimer's? More

> PKC-epsilon pathway offers a new line of attack against cancer cells. Article

Pharma Manufacturing News

> India's Zydus Cadila finds blood pressure med has embedded brown spots. Story

> Ferring preps for first U.S. plant opening as it moves to New Jersey campus. More

> FDA notches a win after Tennessee compounder pleads guilty. Report

> Meda drops Recipharm contract; plant may be forced to close. Story

> Daewoong inks deal to build $188M facility in South Korea. Article

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.